SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Oct 30, 2017
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Oct. 30, 2017 · CIK: 0001585608 · Accession: 0000000000-17-038326
AI Filing Summary & Sentiment
Reasoning
Letter
October 30, 2017 Lisa Conte Chief Executive Officer and President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, California 94105 Jaguar Health, Inc. Registration Statement on Form S-3 Filed October 20, 2017 File No. 333-221041Re: Dear Ms. Conte: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Michael Lee
Show Raw Text
October 30, 2017
Lisa Conte
Chief Executive Officer and President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, California 94105
Jaguar Health, Inc.
Registration Statement on Form S-3
Filed October 20, 2017
File No. 333-221041Re:
Dear Ms. Conte:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Michael Lee